or clopidogrel (75 mg) given once daily. The study was sponsored by the maker of the aspirin/dipyridamole combination (Aggrenox). During a mean follow-up of 2.5 years, recurrent stroke occurred in ...
as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet reactivity. Earlier studies also seem to indicate that reloading patients already on maintenance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback